Hilker R , Thiel A , Geisen C et al. Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome . Lupus2000; 9: 311-316 .
2.
Frances C , Piette JC . The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus . J Autoimmun2000; 15: 139-143 .
3.
Wright RA , Kokmen E . Gradually progressive dementia without discrete cerebrovascular events in a patient with Sneddon's syndrome . Mayo Clin Proc1999; 74: 57-61 .
4.
Juengling FD , Kassubek J , Otte A . Standardization of cerebral PET imaging in clinical neurological diagnostics . Eur J Nucl Med2000; 27: 98-98 .
5.
Asherson RA , Khamashta MA , Gil A et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome . Am J Med1989; 86: 391-399 .
6.
Frances C , Papo T , Wechsler B et al. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients . Medicine (Baltimore)1999; 78: 209-219 .
7.
Zelger B , Sepp N , Stockhammer G et al. Sneddon's syndrome. A longterm follow-up of 21 patients . Arch Dermatol1993; 129: 437-447 .
8.
Font J , Lopez-Soto A , Cervera R et al. The primary antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients . Autoimmunity1991; 9: 69-75 .
9.
Rother E , Lang B , Coldewey R et al. Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus . Clin Rheumatol1993; 12: 31-35 .
10.
Otte A , Weiner SM , Peter HH et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study . Eur J Nucl Med1997; 24: 787-791 .
11.
Aydin N , Utku U , Hüseyin Özer TE . An uncommon central nervous system manifestation in SLE: the diffuse and symmetrical lesions of white matter . Eur J Neurol2000; 7: 585-586 .
